Nada Albarakati

691 citations
15 papers · 421 indexed · h-index 10
Topics
DNA Repair Mechanisms (5 papers)Bladder and Urothelial Cancer Treatments (5 papers)Genomics and Chromatin Dynamics (4 papers)

In The Last Decade

Nada Albarakati

15 papers receiving 418 citations

Peers

Nada Albarakati
Comparison fields: 5 of 56
  • Molecular Biology 346
  • Oncology 161
  • Cancer Research 88
  • Genetics 49
  • Pulmonary and Respiratory Medicine 46
Replace Fernando Martínez‐Arribas with:
Fernando Martínez‐Arribas Spain
Berthold Gierke Germany
Qiliang Lu China
Rabab A. Ahmed Egypt
Masahiko Nezu Japan
Alexander C. Jordan United States
Nora Balint‐Lahat Israel
Gillian N. Kulikowski United States
Sheng-Bang Yang China
Dmytro M. Havaleshko United States
Nada Albarakati relative to Fernando Martínez‐Arribas Spain Fernando Martínez‐Arribas's profile →
Citations per field
00.5×10×20×27×
Fernando Martínez‐Arribas · 1×
Citations per year

Countries citing papers authored by Nada Albarakati

Since Specialization
Citations

This map shows the geographic impact of Nada Albarakati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Albarakati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Albarakati more than expected).

Fields of papers citing papers by Nada Albarakati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada Albarakati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Albarakati. The network helps show where Nada Albarakati may publish in the future.

Co-authorship network of co-authors of Nada Albarakati

This figure shows the co-authorship network connecting the top 25 collaborators of Nada Albarakati. A scholar is included among the top collaborators of Nada Albarakati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada Albarakati. Nada Albarakati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 3
2 7
3 3
4 6
5 12
6 29
7 14
8 55
9 30
10 29
11 65
12 31
13 56
14 77
15 4

About Nada Albarakati

Nada Albarakati is a scholar working on Oncology, Molecular Biology and Cancer Research, having authored 15 papers that have together received 421 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Genomics and Chromatin Dynamics (4 papers). The work is most often cited by research in Oncology (161 citations), Cancer Research (88 citations) and Molecular Biology (346 citations). Nada Albarakati has collaborated with scholars based in United Kingdom, Saudi Arabia and Egypt. Frequent co-authors include Srinivasan Madhusudan, Ian O. Ellis, Emad A. Rakha, Rebeka Sultana, Stephen Chan, Graham Ball, Andrew R. Green, Alaa T. Alshareeda, Tarek M.A. Abdel-Fatah and Ola H. Negm. Their work appears in journals such as PLoS ONE, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026